Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Daisy Alapat"'
Autor:
Amani Erra, Luis Carrillo, Pankaj Mathur, Daisy Alapat, Sravani Gundarlapalli, Sharmilan Thanendrarajan, Lakshmi Yarlagadda, Milan Bimali, Mathew Kottarathara, Maurizio Zangari, Angel A Mitma, Richa Parikh, David Baker, Guido Tricot, Frits van Rhee, Archana Sachedina, Yetunde Ogunsesan, Carolina Schinke, Shadiqul Hoque
Publikováno v:
Haematologica
Not available.
Publikováno v:
European Journal of Haematology. 107:484-488
Unresectable, symptomatic unicentric Castleman disease (UCD) can represent a formidable therapeutic challenge. UCD masses are often highly vascularized offering the opportunity for therapeutic embolization. Herein, we report on 6 patients in which th
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:e551-e555
Autor:
Bart Barlogie, Tushar D. Bhagat, Armin Graber, Ryan Bender, Gaurav Choudhary, Frederick A. Fletcher, Maya Panjikaran, Victor Thiruthuvanathan, Daisy Alapat, Lauryn Keeler, Sarah K. Johnson, Ulrich Steidl, Chirag K Bhagat, Amittha Wickrema, Christoph Heuck, Jiahao Chen, George I. Georgiev, Ian C. MacArthur, Carolina Schinke, Aditi Shastri, Britta Will, Srinivas Aluri, Ashwin Sridharan, Gregory Sims, Niels Weinhold, Mariana da Silva Ferreira, Yu Xia, Amit Verma, Gareth J. Morgan, Kith Pradhan
Publikováno v:
Blood Advances. 3:3962-3967
Therapy-related acute myeloid leukemia and myelodysplastic syndromes (t-AML/t-MDS) are secondary hematologic malignancies associated with poor prognosis, warranting insights into their predisposing conditions and cells of origin. We identified patien
Autor:
Amrit P. Singh, Frank Schmitz, Adam Z. Rosenthal, Madhav V. Dhodapkar, Antje Hoering, Daisy Alapat, Yan Ren, Maurizio Zangari, Kelsie Smith, Samuel A. Danziger, Jake Gockley, Andrew Dervan, Alexander V. Ratushny, Mark McConnell, Robert M. Hershberg, Suzana Couto, Brian A Walker, Faith E. Davies, Alison Fitch, Wilbert B. Copeland, Gareth J. Morgan, Bart Barlogie, Phil Farmer, David J. Reiss, Brian Fox, Mary H. Young, Frits van Rhee, Cody Ashby, Katie Newhall, Nathan Petty, Michael A Bauer, Robert Z. Orlowski, Matthew Trotter
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 17, Iss 11, p e1003323 (2020)
PLoS Medicine, Vol 17, Iss 11, p e1003323 (2020)
Background The tumor microenvironment (TME) is increasingly appreciated as an important determinant of cancer outcome, including in multiple myeloma (MM). However, most myeloma microenvironment studies have been based on bone marrow (BM) aspirates, w
Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma
Autor:
Naveen Yarlagadda, Jeffrey R. Sawyer, Dinesh Atwal, James Lopez, Yadav Pandey, Arya Mariam Roy, Sharmilan Thanendrarajan, Aniko Szabo, Samantha Kendrick, Meera Mohan, Frits van Rhee, Maurizio Zangari, Carolina Schinke, Richa Parikh, Erming Tian, Guido Tricot, Daisy Alapat
Publikováno v:
Blood advances. 6(3)
Multiple myeloma (MM) patients frequently attain a bone marrow (BM) minimal residual disease (MRD) negativity status in response to treatment. We identified 568 patients who achieved BM MRD negativity following autologous stem cell transplantation (A
Persistent bone marrow minimal residual disease as a 'high‐risk' disease feature in multiple myeloma
Autor:
Jeffrey R. Sawyer, Daisy Alapat, Maurizio Zangari, Sravani Gundarlapalli, Samantha Kendrick, Guido Tricot, Meera Mohan, Sharmilan Thanendrarajan, Erming Tian, Frits van Rhee, Carolina Schinke, Naveen Yarlagadda, Aniko Szabo
Publikováno v:
American Journal of Hematology. 96
Autor:
Bart Barlogie, Ruslana Tytarenko, Manoj Kumar, Leo Rasche, Rohan Samant, Cody Ashby, Christopher P. Wardell, Brian A Walker, Sharmilan Thanendrarajan, Faith E. Davies, Michael A Bauer, R. van Hemert, Maurizio Zangari, Joshua Epstein, Carolina Schinke, Daisy Alapat, A F Williams, F. van Rhee, Niels Weinhold, Gareth J. Morgan, Grant Gershner, James E. McDonald
Publikováno v:
Leukemia
Introduction The iliac crest is the usual sampling site for minimal residual disease (MRD) monitoring in Multiple Myeloma (MM). However, the disease distribution in the bone marrow (BM) is often heterogeneous. Functional imaging can be used to comple
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 26(5)
Introduction Cardiac amyloidosis and light chain deposition disease (LCDD) are the most common cause of death in AL amyloidosis or LCDD. Methods Our multiple myeloma database identified 50 patients with cardiac amyloidosis or LCDD between January 200
Autor:
Daisy Alapat, David C. Fajgenbaum, Sheila K Pierson, Frits van Rhee, Thomas S. Uldrick, Adam Bagg, Gordan Srkalovic, Mary Jo Lechowicz, Megan S. Lim
Publikováno v:
Blood. 138:1622-1622
Castleman disease (CD) describes a group of heterogeneous lymphoproliferative disorders with characteristic histopathology that are classified based on the number of enlarged lymph node (LN) stations, etiological drivers, and clinical phenotype. CD h